FDA Adverse Event Other Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 1903628 · Received November 16, 2010

Report

Report Number
3004464228-2010-01365
Event Type
Other
Date Received
November 16, 2010
Date of Event
October 16, 2010
Report Date
October 16, 2010
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER STATED THAT THE CANNULA HAD DEPLOYED LATE FROM THE POD. THIS INDICATES THAT THE NEEDLE MECHANISM POSSIBLY MALFUNCTIONED DUE TO A DAMAGED COMPONENT. SINCE THE POD WAS NOT RETURNED FOR EVALUATION, HOWEVER, NO MALFUNCTION CAN BE CONFIRMED. THE OMNIPOD USER GUIDE INSTRUCTS USERS TO "CHECK THE INFUSION SITE AFTER INSERTION" TO ENSURE THAT THE CANNULA IS SEATED PROPERLY. IF LABELING INSTRUCTIONS WERE PROPERLY FOLLOWED, THE USER WOULD HAVE NOTICED THAT THE CANNULA HADN'T DEPLOYED (WHICH WOULD HAVE BEEN VISIBLE THROUGH THE POD'S VIEWING PORT) AND WOULD HAVE IMMEDIATELY DEACTIVATED THE DEVICE. THE USER GUIDE ALSO ADVISES USERS TO CHECK THEIR BLOOD GLUCOSE LEVELS FREQUENTLY SO THEY'RE ABLE TO REACT QUICKLY AND APPROPRIATELY TO ANY ISSUES.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT SHE WAS EXPERIENCING HIGH BG LEVELS (345-376MG/DL) AND HAD CHANGED TO A NEW POD. DESPITE THE APPLICATION OF THE NEW DEVICE, HER HIGH BG LEVELS PERSISTED. SHE REPORTED THAT THE NEW POD HAD "DEPLOYED THE CANNULA LATE"; THE CANNULA ONLY DEPLOYED AFTER THE POD WAS REMOVED. THE POD WILL BE RETURNED FOR EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200 L30341

Patients

Seq Age Sex Outcome Treatment
1 48 YR Other